Shedding new light on nerve cell growth
News Jul 11, 2014
Amidst the astounding complexity of the billions of nerve cells and trillions of synaptic connections in the brain, how do nerve cells decide how far to grow or how many connections to build? How do they coordinate these events within the developing brain?
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) have shed new light on these complex processes, showing that a particular protein plays a far more sophisticated role in neuron development than previously thought.
The study, published in the journal PLOS Genetics, focuses on the large, intracellular signaling protein RPM-1 that is expressed in the nervous system. TSRI Assistant Professor Brock Grill and his team show the surprising degree to which RPM-1 harnesses sophisticated mechanisms to regulate neuron development.
Specifically, the research sheds light on the role of RPM-1 in the development of axons or nerve fibers -- the elongated projections of nerve cells that transmit electrical impulses away from the neuron via synapses. Some axons are quite long; in the sciatic nerve, axons run from the base of the spine to the big toe.
"Collectively, our recent work offers significant evidence that RPM-1 coordinates how long an axon grows with construction of synaptic connections," said Grill. "Understanding how these two developmental processes are coordinated at the molecular level is extremely challenging. We've now made significant progress."
Putting Together the Pieces
The study describes how RPM-1 regulates the activity of a single protein known as DLK-1, a protein that regulates neuron development and plays an essential role in axon regeneration. RPM-1 uses PPM-2, an enzyme that removes a phosphate group from a protein thereby altering its function, in combination with ubiquitin ligase activity to directly inhibit DLK-1.
"Studies on RPM-1 have been critical to understanding how this conserved family of proteins works," said Scott T. Baker, the first author of the study and a member of Grill's research team. "Because RPM-1 plays multiple roles during neuronal development, you wouldn't want to interfere with it. But exploring the role of PPM-2 in controlling DLK-1 and axon regeneration could be worthwhile -- and could have implications in neurodegenerative diseases."
The Grill lab has also explored other aspects of how RPM-1 regulates neuron development. A related study, also published in PLOS Genetics, shows that RPM-1 functions as a part of a novel pathway to control β-catenin activity -- this is the first evidence that RPM-1 works in connection with extracellular signals, such as a family of protein growth factors known as Wnts, and is part of larger signaling networks that regulate development. A paper in the journal Neural Development shows that RPM-1 is localized at both the synapse and the mature axon tip, evidence that RPM-1 is positioned to potentially coordinate the construction of synapses with regulation of axon extension and termination.
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Karla J Opperman, Brock Grill. RPM-1 is localized to distinct subcellular compartments and regulates axon length in GABAergic motor neurons. Neural Development, Published May 10 2014. doi: 10.1186/1749-8104-9-10
Erik D. Tulgren, Shane M. Turgeon, Karla J. Opperman, Brock Grill. The Nesprin Family Member ANC-1 Regulates Synapse Formation and Axon Termination by Functioning in a Pathway with RPM-1 and β-Catenin. PLoS Genetics, Published July 10 2014. doi: 10.1371/journal.pgen.1004481
Scott T. Baker, Karla J. Opperman, Erik D. Tulgren, Shane M. Turgeon, Willy Bienvenut, Brock Grill. RPM-1 Uses Both Ubiquitin Ligase and Phosphatase-Based Mechanisms to Regulate DLK-1 during Neuronal Development. PLoS Genetics, Published May 8 2014. doi: 10.1371/journal.pgen.1004297
Combination Chemotherapy Could Significantly Improve Deadly Brain Tumor TreatmentNews
A team led by Massachusetts General Hospital (MGH) investigators has found that adding the chemotherapy drug hydroxyurea to the current chemotherapy protocol for glioblastoma significantly increased survival in animal models.READ MORE
Purine Synthesis in Neuron-Like Cells InvestigatedNews
Neuron-like cells created from a readily available cell line have allowed researchers to investigate how the human brain makes a metabolic building block essential for the survival of all living organisms.READ MORE
All in a Droplet: Atomic Resolution of ALS Protein ResolvedNews
Researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.READ MORE